Vandana Singh

Weinstein-Ackman Consortium Raises Bid for Sculptor Capital, Poses Challenge to Rithm

In a surprising development, a consortium led by Boaz Weinstein and backed by notable investors William Ackman and Marc Lasry, has increased its offer for Sculptor Capital Management (SCU). The revised bid of approximately $13 per share exceeds...

RedHill Biopharma: A Promising Israel-Based Penny Stock Making Strides in the Ebola Virus Fight

Shares of RedHill Biopharma Ltd (RDHL) are gaining momentum following a significant development in the company's fight against the Ebola virus. RedHill recently announced that its oral opaganib has shown a remarkable increase in survival time in a...

Fusion Pharmaceuticals: The Future of Targeted Cancer Therapies, According to Oppenheimer

Oppenheimer, a leading investment firm, has recently initiated coverage on Fusion Pharmaceuticals Inc (NASDAQ: FUSN), highlighting the company's robust pipeline in targeted radionuclide therapies (TRTs). With three TRTs currently in clinical development, Fusion Pharmaceuticals is poised to be...

Bionomics Delivers Promising Results in PTSD Treatment Trial – Analysts Express Optimism

Bionomics Limited (NASDAQ: BNOX) has announced the topline results from its Phase 2b ATTUNE trial of BNC210 for post-traumatic stress disorder (PTSD). The trial met its primary endpoint of change in the Clinician-Administered PTSD Scale for...

Imunon Presents Encouraging Early Data on IMNN-001 in Ovarian Cancer

Imunon Inc (NASDAQ: IMNN) has released interim data from its Phase 1/2 OVATION 2 Study, presenting promising results for IMNN-001 in combination with neoadjuvant chemotherapy (NACT). The study focuses on newly diagnosed...

BioLineRx Reveals Positive Results from Clinical Trial for First Line Pancreatic Cancer Treatment

BioLineRx Ltd (NASDAQ: BLRX) has announced encouraging data from the single-arm pilot phase of the investigator-initiated CheMo4METPANC Phase 2 combination trial. The trial evaluated the effectiveness of motixafortide and gemcitabine and nab-paclitaxel in combination versus gemcitabine and nab-paclitaxel...

Allakos' Antibodies For Chronic Skin Conditions, Analyst Sees Over 400% Stock Upside

JMP Securities Initiates Coverage on Allakos Inc (NASDAQ: ALLK)JMP Securities has recently initiated coverage on Allakos Inc (ALLK), highlighting the potential of their novel monoclonal antibodies that target receptors responsible for driving multiple diseases.Lead analyst Jonathan Wolleben maintains...

Seelos Therapeutics' Aggressive Alzheimer's Hopeful Candidate Shows Encouraging Preclinical Activity

Seelos Therapeutics Inc (NASDAQ: SEEL) has released preclinical data from a study evaluating SLS-005, its investigational drug for Alzheimer's disease, in an aggressive non-human primate model. The study utilized tau overexpression in older non-human primates through bilateral AAV-induced...

Inozyme Pharma Posts Encouraging Data From Rare Calcification Disorders

Inozyme Pharma Inc, trading under the ticker symbol INZY on the NASDAQ, has announced promising interim results from its Phase 1/2 trials of INZ-701 for the treatment of ENPP1 Deficiency and ABCC6 Deficiency in adults.The trials have shown...

Vapotherm's Asthma Therapy More Effective Than Standard Oxygen Therapy In Kids

Vapotherm Inc (NASDAQ: VAPO) has presented the findings of an investigator-initiated clinical trial at the European Respiratory Society International Congress 2023. The trial focused on the use of high flow humidified oxygen as an...